will hims stop selling semaglutide Novo Nordisk, & Hers settle GLP-1 drug dispute Hims to stop offering copy
Description
The dosage is usually increased gradually, with the initial starting dose being 3 mg, then increasing to 7 mg after 30 days
The BUD is calculated from the date of compounding, not the date of delivery or first use
Rapid loss needs: Microdosing delays therapeutic doses
Slower up-titration might be helpful to further minimize the risk of GI symptoms
Active ingredient: Semaglutide, a GLP-1 receptor agonist
Clinical trial averages suggest 48 pounds monthly initially, but your actual results depend on genetics, starting weight, and lifestyle
